Clinical Trial Update: S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating S1312 (inotuzumab ozogamicin) with combination chemotherapy in adults with relapsed or refractory acute leukemias; study status complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Lymphoma
• Leukemia

Drugs mentioned

• Inotuzumab ozogamicin (inotuzumab ozogamicin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Acute Leukemias of Ambiguous Lineage, B-cell Adult Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2022-04-06